Parkinson Clinical Trial
— VTIMEOfficial title:
V-TIME: A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults, Patients With Parkinson's Disease and Individuals With Mild Cognitive Impairments
The proposed randomized controlled trial will evaluate the effects of treadmill training
augmented with virtual reality on fall risk.
300 older adults with a history of falls will be recruited to participate in this study.
This will include older adults (n=100), patients with mild cognitive impairment (MCI)
(n=100), and patients with Parkinson's disease (PD)(n=100). Subjects will be randomly
assigned to the intervention group (treadmill training with virtual reality) or to the
active-control group (treadmill training without virtual reality). Each person will
participate in a training program set in an outpatient setting 3 times per week for 6 weeks.
Assessments will take place before, after, and 1 month and 6 months after the completion of
the training.
Status | Completed |
Enrollment | 302 |
Est. completion date | December 2015 |
Est. primary completion date | April 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 60 Years to 85 Years |
Eligibility |
Inclusion Criteria: - 2 or more falls within 6 months prior to the beginning of the study - Aged 60-85 years - Able to walk for 5 minutes unassisted - Adequate hearing and vision capabilities. - Stable medication for the past 1 month and anticipated over a period of 6 months Exclusion Criteria: - Psychiatric co-morbidity - Clinical diagnosis of dementia or other severe cognitive impairment (MMSE<24) - History of stroke, traumatic brain injury or other neurological disorders (other than PD and MCI, for those groups) - Acute lower back or lower extremity pain, peripheral neuropathy, rheumatic and orthopaedic diseases - Unstable medical condition in the past 6 months - Unable to comply with the training - Interfering therapy |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Belgium | Department of Rehabilitation Sciences, Katholieke Universiteit Leuven | Leuven | |
Israel | Tel Aviv Sourasky Medical Center | Tel Aviv | |
Italy | Department of Neurosciences Universita Degli Studi Di Genova, Italy | Genova | |
Netherlands | Department of Geriatric Medicine and Neurology, Radboud University Nijmegen Medical Center The Netherlands | Nijmegen | |
United Kingdom | Institute for Aging and Health, University of Newcastle, UK | Newcastle |
Lead Sponsor | Collaborator |
---|---|
Tel-Aviv Sourasky Medical Center | Katholieke Universiteit Leuven, Newcastle University, Universita degli Studi di Genova, University Medical Center Nijmegen |
Belgium, Israel, Italy, Netherlands, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Falls rate | The primary outcome measure of the study is fall rate. Participants will keep a falls calendar for 6 months post intervention. Each time the participant falls he/she will tick the date on the calendar. These calendars will be returned to the researchers once a month in a pre-addressed envelope. | 6 months post intervention | No |
Secondary | Gait | Gait speed and gait variability under usual and dual task conditions and while negotiating physical obstacles will be measured. Participants will be asked to walk in a well-lit corridor under 3 conditions each of 1 minute: i) walking in a comfortable speed, ii) walking while subtracting 3s from a predefined number (dual task), iii) walking while negotiating two obstacles placed on the floor at specific locations. Spatial-temporal gait characteristics (e.g., gait speed (m/s), stride length (m), stride time (s), swing time (%), asymmetry, and step width (cm)) will be determined. Endurance will be assessed using the 2 Minute Walk Test. | 6 months post intervention | No |
Secondary | Cognitive function | Cognitive function will be assessed using a computerized neuropsychological test battery (Mindstreams, NeuroTrax Corp., NJ). In addition, we will also include standardized neuropsychological tests such as the Montreal Cognitive Assessment (MoCA); The Trail Making Test (TMT) and the Verbal Fluency test. | 6 months post intervention | No |
Secondary | Balance and mobility | The Four Square Step Test (FSST), The Short Physical Performance Battery (SPPB) and the mini-Balance Evaluation Systems Test (mini-BESTest) will be used to assess mobility. Community ambulation will be assessed using The Physical Activity Scale for the Elderly (PASE) and a tri-axial accelerometer (Axivity Ltd.) which will be worn by the participants for 7 days to quantify and monitor stepping and physical activity. | 6 months post intervention | No |
Secondary | Quality of life | The SF-36 Health Survey, a generic self-report questionnaire designed to address health related quality of life will be used. Fear of Falling will be evaluated using the Falls Efficacy Scale-International. | 6 months post intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06037590 -
A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA®
|
Phase 1 | |
Recruiting |
NCT01537224 -
Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information
|
N/A | |
Withdrawn |
NCT04011449 -
State-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With DBS Using the Medtronic RC+S
|
N/A | |
Completed |
NCT02539446 -
Suprapostural Attention Focus and Postural Difficulty on H-reflex and Brain Activity: Aging and Parkinson's Disease
|
N/A | |
Completed |
NCT00358189 -
Effects of Deep Brain Stimulation for the Treatment of Parkinson's Disease
|
N/A | |
Active, not recruiting |
NCT04606979 -
tDCS of the Primary Motor Cortex to Improve Implicit Motor Sequence Learning in Parkinson's Disease
|
N/A | |
Completed |
NCT05119803 -
The Relationship of Spine Posture and Mobility With Upper Extremity Functions in Parkinson's Patients
|
||
Recruiting |
NCT06154772 -
Quality of Life, Anxiety and Fatigue Level of Parkison's Patients With Color Therapy
|
N/A | |
Not yet recruiting |
NCT02249715 -
Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease
|
N/A | |
Completed |
NCT03232996 -
Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease.
|
N/A | |
Enrolling by invitation |
NCT04566341 -
Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease
|
||
Active, not recruiting |
NCT04978597 -
Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)
|
Phase 3 | |
Recruiting |
NCT06116084 -
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine
|
N/A | |
Recruiting |
NCT05830396 -
GRoningen Early-PD Ambroxol Treatment
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05379062 -
Choral Singing for Patients With Parkinson's
|
N/A | |
Completed |
NCT02071823 -
Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules
|
Phase 1 | |
Recruiting |
NCT03558568 -
The Effect of Deep Brain Stimulation on Facial Expressions.
|
N/A | |
Enrolling by invitation |
NCT05596201 -
Super-resolution of Brain Magnetic Resonance Images in Deep Brain Stimulation for Parkinson's Disease
|
||
Recruiting |
NCT04181918 -
Action Observation Treatment in Parkinson's Patients
|
N/A | |
Completed |
NCT02305277 -
Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers
|
Phase 1 |